Malaria Diagnostics Market Size, Share, and COVID-19 Impact Analysis By Product (Instruments and Kits and Reagents and Consumables), By Type (Lab-based Test and Point of Care Test), By Technique (Polymerase Chain Reaction, Immunochromatography, Fluorescent In-situ Hybridization, DNA Microarrays, and Others), By End Users (Hospitals and Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

The global malaria diagnostics market size was valued at USD 0.79 billion in 2025. The market is projected to grow from USD 0.81 billion in 2026 to USD 1. billion by 2034, exhibiting a CAGR of 2.64% during the forecast period.

The continuous variation in climatic conditions such as temperature, rainfall, and humidity is one of the profound reasons for the development of the malaria parasite. In addition to this, poor sanitation, and consumption of unclean drinking water are some of the factors contributing to the increase in the prevalence of malaria across the globe, among which developing countries are the major contributors. To forbid this rising prevalence, healthcare authorities of different countries have taken certain initiatives to create awareness among the general population.

• For instance, according to the statistics published by World Health Organization (WHO) in the world malaria report 2021, there were 241.0 million malaria patients in 2020 globally, witnessing a growth of 6.1% as compared to 227.0 million patients in 2019.
• Among these, there were 5.0 million cases estimated from Southeast Asia in which India was the largest contributor of 82.5% of the malaria cases, followed by Indonesia and Myanmar, where the contribution of cases was 15.6% and 1.6%.

The strategies and efforts by healthcare authorities for the eradication of malaria, have evolved with time. The majority of the initiatives and activities are focused on creating awareness about the disease, improving accessibility of the treatment, and on the expansion of the efforts to control the disease.

• For example, according to an article published by KAISER FAMILY FOUNDATION in October 2022, the U.S. released the goals of the president’s malaria initiative strategy 2021-2026. The initiative aims to reduce the malaria mortality rate by one-third in the president’s malaria initiative (PMI) supported countries and achieve a reduction of 80.0% in cases compared to the year 2015.
• Also, according to an article published by the Ministry of Health and family welfare in July 2021, the government of India has launched a national framework for malaria elimination whose major intervention is the early diagnosis of the disease by using rapid diagnostic test kits.  

According to the statistics published by World Health Organization (WHO) in the world malaria report, malaria is responsible for around 400,000 deaths worldwide each year. The use of early detection test kits and preventative medicine can assist in reducing the numbers and can also aid in resisting the transmission of the disease. This rising demand has encouraged numerous companies to launch test kits for malaria diagnosis which are being used by healthcare professionals in different government-run programs.

• For instance, in July 2021, the president of Kenya unveiled the locally developed malaria rapid diagnostic test (RDT) kit. The mass production of the test kits is to be done through a public-private partnership and has aimed to increase the accessibility of malaria diagnosis.
• In April 2021, Jiangsu Bioperfectus Technologies Co., Ltd., launched a real-time plasmodium DNA PCR kit. The test kit aids in the identification of plasmodium with specific DNA and can conduct 96 tests in 61 minutes.

Impact of COVID-19 on the Medical Tourism Market

The emergence of COVID-19 has impeded the demand for malaria diagnostics test kits, as the diagnostic testing rates were affected during the pandemic. The reallocation of healthcare resources, reduced number of patients’ visits to the hospitals, and disruptions in the supply chains have majorly affected the sales of malaria diagnostics kits. Also, different initiatives driven by healthcare regulatory authorities for the testing of malaria were hampered during the pandemic. For instance, according to the statistics published by the world health organization (WHO) in 2021, 15 countries which are reported a high burden of malaria, noted a reduction of more than 20.0% in testing of malaria during the pandemic.

However, as many countries have relaxed travel restrictions post-pandemic the number of patient visits to the hospital increased, which led to an increase in the diagnosis of malaria cases. Also, the government initiatives that were hampered during the course were commenced and observed recovery after the COVID-19 pandemic.   

Key Insights

The report will cover the following key insights:

• Prevalence of Malaria- By Key Countries/ Regions (2022).
• New Product Launches, By Key Players.
• Key Industry Developments- Mergers & Acquisitions.
• Technological Advancements in the Market.
• Impact of COVID-19 on the Market.

Analysis by Technology

The rapid diagnostics tests segment is projected to grow at a rapid rate during the forecast period. The utilization of rapid diagnostics test kits by hospitals, clinics, and government health regulatory organizations is contributing to the growth of the segment.

• For instance according to an article published by the national library of Medicine in June 2021, globally 348.0 million rapid diagnostic tests (RTDs) were sold by manufacturers and 267.0 million were distributed by national malaria programs.  

Regional Analysis

To gain extensive insights into the market, Download for Customization

The rising prevalence of the disease has emphasized regulatory authorities for initiating awareness campaigns in general population, and this is leading to increase in the utilization of the diagnostics kits in North America. Also, the emphasis of researchers on develsopment and introduction of advanced test kits for the detection of disease is contributing for the growth of the markets.

• For instance, in June 2021, MM Activ Sci-Tech communications published an article which stated that, a team of scientists from Nanyang Technological University, Singapore have developed a test kit for detection of malaria. The kit works by detection of hemozoin, a by-product formed from the digestion of blood by malaria parasites.

Key Players Covered

The report will include the profiles of key players such as ACCESS BIO, Premier Medical, bioMérieux SA, Meril Life Sciences Pvt. Ltd., Bio-Rad Laboratories, Inc., Nanjing Synthgene Medical Technology Co., Ltd., Hangzhou Testsea biotechnology co., LTD and others.

Segmentation

Key Industry Developments

Emphasis of key manufacturers on introduction of new techniques for diagnosis of malaria is contributing for the growth of the market.

• October 2021: Sysmex America Inc., one of the leading diagnostic solution company launched XN-30, an automated hematology analyzer for the detection of malaria. This new analyzer is aids in improvement of workflow and is meant for research use only.
• May 2021: HORIBA Medical introduced the option of malaria screening on their ABX Pentra XL80 and Pentra XLR analyzer. Introduction of this technology aided as a great boon for diagnostic labs